{"id":68745,"date":"2026-02-20T17:22:38","date_gmt":"2026-02-20T17:22:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68745"},"modified":"2026-05-21T07:14:12","modified_gmt":"2026-05-21T07:14:12","slug":"bpc-157","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/bpc-157\/","title":{"rendered":"BPC-157"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je BPC-157?<\/h3>\n<p style=\"margin: 0;\"><strong>BPC-157<\/strong> (Body Protection Compound 157) je syntetick\u00fd pentadekapeptid slo\u017een\u00fd z 15 aminokyselin, odvozen\u00fd z ochrann\u00e9ho \u017ealude\u010dn\u00edho proteinu. V publikovan\u00fdch preklinick\u00fdch studi\u00edch prok\u00e1zal konzistentn\u00ed \u00fa\u010dinky na regeneraci \u0161lach, vaz\u016f, st\u0159ev, sval\u016f a c\u00e9vn\u00ed tk\u00e1n\u011b prost\u0159ednictv\u00edm signalizace VEGF, oxidu dusnat\u00e9ho a receptor\u016f r\u016fstov\u00e9ho hormonu. Dod\u00e1v\u00e1 se v lyofilizovan\u00fdch vialk\u00e1ch o obsahu 2 mg a\u017e 10 mg v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1419.55 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd pr\u00e1\u0161ek (nebo v dodan\u00e9 form\u011b)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00e9: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00e9: 2\u20138 \u00b0C, pou\u017eijte do ~30 dn\u016f. Chra\u0148te p\u0159ed sv\u011btlem. Nefreeze\u2013thaw rekonstituovan\u00fd roztok.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Co je BPC-157?<\/h2>\n<p><strong>BPC-157<\/strong> je zkratka pro <strong>Body Protection Compound 157<\/strong>, syntetick\u00fd pentadekapeptid slo\u017een\u00fd z 15 aminokyselin, p\u016fvodn\u011b izolovan\u00fd jako fragment v\u011bt\u0161\u00edho ochrann\u00e9ho proteinu nach\u00e1zej\u00edc\u00edho se v lidsk\u00e9 \u017ealude\u010dn\u00ed \u0161\u0165\u00e1v\u011b. Na rozd\u00edl od v\u011bt\u0161iny peptid\u016f je stabiln\u00ed v \u017ealude\u010dn\u00ed kyselin\u011b, co\u017e z n\u011bj \u010din\u00ed \u010dast\u00fd p\u0159edm\u011bt v\u00fdzkumu peror\u00e1ln\u00edho pod\u00e1v\u00e1n\u00ed v modelech na hlodavc\u00edch vedle b\u011b\u017en\u011bj\u0161\u00ed subkut\u00e1nn\u00ed cesty. BPC-157 je jedn\u00edm z nejv\u00edce studovan\u00fdch peptid\u016f v preklinick\u00e9 literatu\u0159e zam\u011b\u0159en\u00e9 na hojen\u00ed, s publikovan\u00fdmi pracemi zahrnuj\u00edc\u00edmi \u0161lachy, vazy, st\u0159evn\u00ed bari\u00e9ru, kostern\u00ed svalstvo, kosti a c\u00e9vn\u00ed tk\u00e1\u0148.<\/p>\n<p>Sekvence peptidu je GEPPPGKPADDAGLV, molekulov\u00e1 hmotnost p\u0159ibli\u017en\u011b 1 419 Da, empirick\u00fd vzorec C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub>. Dod\u00e1v\u00e1 se jako lyofilizovan\u00fd pr\u00e1\u0161ek vysok\u00e9 \u010distoty pro rekonstituci s bakteriostatickou vodou. BPC-157 je <strong>ur\u010den pouze pro laboratorn\u00ed v\u00fdzkum<\/strong> a nen\u00ed ur\u010den pro lidskou nebo veterin\u00e1rn\u00ed diagnostiku \u010di terapii. Pro podrobn\u00e9 informace o mechanismu \u00fa\u010dinku, publikovan\u00fdch klinick\u00fdch studi\u00edch a d\u00e1vkov\u00e1n\u00ed ve v\u00fdzkumu viz na\u0161e pln\u00e9 <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-peptide-healing-recovery-guide\/\">v\u00fdzkumn\u00e1 p\u0159\u00edru\u010dka BPC-157<\/a>.<\/p>\n<h2>Mechanismus \u00fa\u010dinku \u2014 T\u0159i p\u0159ekr\u00fdvaj\u00edc\u00ed se l\u00e9\u010debn\u00e9 dr\u00e1hy<\/h2>\n<p>Co odli\u0161uje BPC-157 od jedno\u00fa\u010delov\u00fdch peptid\u016f, je jeho <strong>sou\u010dasn\u00e1 aktivita ve t\u0159ech odli\u0161n\u00fdch signaliza\u010dn\u00edch drah\u00e1ch<\/strong>, z nich\u017e ka\u017ed\u00e1 p\u0159isp\u00edv\u00e1 k pozorovan\u00e9mu fenotypu regenerace tk\u00e1n\u00ed v publikovan\u00fdch v\u00fdzkumech:<\/p>\n<ul>\n<li><strong>Angiogeneze \/ regulace VEGF nahoru<\/strong> \u2014 BPC-157 zvy\u0161uje expresci receptoru pro vaskul\u00e1rn\u00ed endoteli\u00e1ln\u00ed r\u016fstov\u00fd faktor 2 (VEGFR2) v po\u0161kozen\u00e9 tk\u00e1ni, co\u017e podporuje tvorbu nov\u00fdch kapil\u00e1r. Toto zlep\u0161uje lok\u00e1ln\u00ed perfuzi v m\u00edstech opravy, co\u017e je limituj\u00edc\u00ed krok v hojen\u00ed \u0161lach, vaz\u016f a sval\u016f.<\/li>\n<li><strong>Drasl\u00edkov\u00e1 (NO) dr\u00e1ha<\/strong> \u2014 BPC-157 zvy\u0161uje aktivitu endoteli\u00e1ln\u00ed synt\u00e1zy oxidu dusnat\u00e9ho (eNOS) a chr\u00e1n\u00ed c\u00e9vn\u00ed endotel p\u0159ed oxida\u010dn\u00edm po\u0161kozen\u00edm. U hlodav\u010d\u00edch model\u016f port\u00e1ln\u00ed hypertenze, syst\u00e9mov\u00e9 vazokonstrikce a \u017ealude\u010dn\u00edch v\u0159ed\u016f je tento efekt kl\u00ed\u010dov\u00fd pro protektivn\u00ed \u00fa\u010dinek slou\u010deniny.<\/li>\n<li><strong>Upregulace receptoru r\u016fstov\u00e9ho hormonu<\/strong> \u2014 BPC-157 zvy\u0161uje expresci receptoru r\u016fstov\u00e9ho hormonu (GHR) na fibroblastech a tenocytech, \u010d\u00edm\u017e zlep\u0161uje synt\u00e9zu kolagenu typu I. Tento mechanismus je pova\u017eov\u00e1n za z\u00e1klad pozorovan\u00e9ho zv\u00fd\u0161en\u00ed pevnosti \u0161lach v modelech transekce Achillovy \u0161lachy a medi\u00e1ln\u00edho kolater\u00e1ln\u00edho vazu.<\/li>\n<\/ul>\n<p>Proto\u017ee tyto t\u0159i dr\u00e1hy konverguj\u00ed v po\u0161kozen\u00e9 tk\u00e1ni, BPC-157 vykazuje rychlej\u0161\u00ed a \u00fapln\u011bj\u0161\u00ed zotaven\u00ed ne\u017e intervence zam\u011b\u0159en\u00e9 na jedinou dr\u00e1hu ve stejn\u00fdch modelech. Je tak\u00e9 v\u00fdrazn\u011b dob\u0159e tolerov\u00e1n v cel\u00e9m rozsahu publikovan\u00fdch d\u00e1vek, s minim\u00e1ln\u00edmi ne\u017e\u00e1douc\u00edmi sign\u00e1ln\u00edmi \u00fa\u010dinky popsan\u00fdmi v toxikologick\u00e9m v\u00fdzkumu.<\/p>\n<h2>Publikovan\u00e9 v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>BPC-157 se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu zam\u011b\u0159en\u00e9m na:<\/p>\n<ul>\n<li><strong>Zotaven\u00ed po poran\u011bn\u00ed \u0161lach a vaz\u016f<\/strong> \u2014 modely transekce Achillovy \u0161lachy, ruptury medi\u00e1ln\u00edho kolater\u00e1ln\u00edho vazu a natr\u017een\u00ed rot\u00e1torov\u00e9 man\u017eety u hlodavc\u016f (Chang et al., J Appl Physiol 2011; Staresinic et al., J Orthop Res 2003)<\/li>\n<li><strong>Integrita st\u0159evn\u00ed bari\u00e9ry a v\u00fdzkum v\u0159ed\u016f<\/strong> \u2014 modely \u017ealude\u010dn\u00edch v\u0159ed\u016f, kolitidy a z\u00e1n\u011btliv\u00fdch st\u0159evn\u00edch onemocn\u011bn\u00ed; \u017ealude\u010dn\u00ed p\u016fvod BPC-157 je zde mechanisticky relevantn\u00ed (Sikiric et al., Curr Med Chem 2011)<\/li>\n<li><strong>Regenerace kostern\u00edho svalstva<\/strong> \u2014 v\u00fdzkum kinetiky zotaven\u00ed po poran\u011bn\u00ed, proliferace myoblast\u016f a tvorby myotub<\/li>\n<li><strong>V\u00fdzkum kloub\u016f a chrupavky<\/strong> \u2014 modely osteoartr\u00f3zy u hlodavc\u016f, slo\u017een\u00ed chrupav\u010dit\u00e9 matrix, synov\u00e1ln\u00ed z\u00e1n\u011bt<\/li>\n<li><strong>C\u00e9vn\u00ed angiogeneze<\/strong> \u2014 tvorba nov\u00fdch kapil\u00e1r a perfuze v m\u00edstech po\u0161kozen\u00e9 tk\u00e1n\u011b<\/li>\n<li><strong>Hojen\u00ed kost\u00ed<\/strong> \u2014 tvorba frakturn\u00edho kallu v modelech v\u00fdzkumu osteotomie a kostn\u00edch defekt\u016f<\/li>\n<li><strong>Srovn\u00e1vac\u00ed v\u00fdzkum hojen\u00ed<\/strong> \u2014 benchmarkov\u00e1n\u00ed v\u016f\u010di jin\u00fdm hojiv\u00fdm peptid\u016fm, zejm\u00e9na <a href=\"https:\/\/medsbase.com\/cs\/tb-500\/\">TB-500 (Thymosin Beta-4)<\/a> jako kanonick\u00fd syst\u00e9mov\u00fd srovn\u00e1vac\u00ed faktor hojen\u00ed. Viz <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-vs-tb-500-comparison-guide\/\">srovn\u00e1n\u00ed BPC-157 vs TB-500<\/a> pro \u00fapln\u00e9 srovn\u00e1n\u00ed.<\/li>\n<\/ul>\n<p>Pro \u0161ir\u0161\u00ed kontext, kam BPC-157 zapad\u00e1 v r\u00e1mci hojiv\u00fdch peptid\u016f, viz <a href=\"https:\/\/medsbase.com\/cs\/best-peptides-for-muscle-recovery\/\">nejlep\u0161\u00ed peptidy pro regeneraci sval\u016f<\/a> p\u0159ehledov\u00fd \u010dl\u00e1nek a <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu m\u011b\u010fnat\u00fd peptid<\/a> jako dopl\u0148kov\u00fd v\u00fdzkumn\u00fd anti-aging prost\u0159edek. Prohl\u00e9dn\u011bte si cel\u00fd <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalog v\u00fdzkumn\u00fdch peptid\u016f<\/a> pro p\u0159\u00edbuzn\u00e9 slou\u010deniny.<\/p>\n<h2>Dostupn\u00e9 s\u00edly a koncentrace<\/h2>\n<p>MedsBase nab\u00edz\u00ed BPC-157 v n\u00e1sleduj\u00edc\u00edch lyofilizovan\u00fdch velikostech vialek. Ka\u017ed\u00e1 varianta je dod\u00e1v\u00e1na v balen\u00edch po 10, 20 a 30 vialk\u00e1ch s kompletn\u00edm n\u00e1vodem k rekonstituci:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">S\u00edla vialky<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typick\u00e9 pou\u017eit\u00ed<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Velikosti balen\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kr\u00e1tk\u00e9 v\u00fdzkumn\u00e9 protokoly, pilotn\u00ed d\u00e1vkov\u00e1n\u00ed, titrace<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standardn\u00ed v\u00fdzkumn\u00e1 s\u00edla, nej\u010dast\u011bji objedn\u00e1van\u00e1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Roz\u0161\u00ed\u0159en\u00e9 v\u00fdzkumn\u00e9 protokoly, nejni\u017e\u0161\u00ed cena za mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>V\u0161echny t\u0159i s\u00edly maj\u00ed stejnou chemickou formu (lyofilizovan\u00fd pr\u00e1\u0161ek, \u010distota HPLC 99%+). Vysokod\u00e1vkov\u00e9 lahvi\u010dky vy\u017eaduj\u00ed men\u0161\u00ed objemy rekonstituce na jednotku d\u00e1vky, co\u017e je u\u017eite\u010dn\u00e9, kdy\u017e v\u00fdzkumn\u00edci cht\u011bj\u00ed minimalizovat objem injekce v protokolech pro hlodavce.<\/p>\n<h2>Srovn\u00e1n\u00ed \u2014 BPC-157 vs TB-500<\/h2>\n<p>BPC-157 a <a href=\"https:\/\/medsbase.com\/cs\/tb-500\/\">TB-500<\/a> jsou dva nej\u010dast\u011bji citovan\u00e9 peptidy ve v\u00fdzkumu hojen\u00ed. \u010casto se studuj\u00ed paraleln\u011b, proto\u017ee p\u016fsob\u00ed komplement\u00e1rn\u00edmi, z velk\u00e9 \u010d\u00e1sti nep\u0159ekr\u00fdvaj\u00edc\u00edmi se mechanismy. Mnoho preklinick\u00fdch protokol\u016f je kombinuje sp\u00ed\u0161e ne\u017e pou\u017e\u00edv\u00e1 samostatn\u011b.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosin Beta-4)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>D\u00e9lka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 aminokyselin (pentadekapeptid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 aminokyselin (thymick\u00fd peptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e1rn\u00ed mechanismus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + upregulace receptoru GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sekvestrace G-aktinu, migrace bun\u011bk<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribuce<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lokalizovan\u011bj\u0161\u00ed v m\u00edst\u011b injekce<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Syst\u00e9mov\u00e9, \u0161iroce distribuovan\u00e9<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132x denn\u011b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg, 2x t\u00fddn\u011b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Nejsiln\u011bj\u0161\u00ed v\u00fdzkumn\u00fd sign\u00e1l<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u0160lachy, vazy, st\u0159evn\u00ed bari\u00e9ra<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Srde\u010dn\u00ed, syst\u00e9mov\u00e9 svalstvo, c\u00e9vn\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Kombinov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00fdzkumn\u011b \u010dasto pod\u00e1v\u00e1no spole\u010dn\u011b s TB-500<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00fdzkumn\u011b \u010dasto pod\u00e1v\u00e1no spole\u010dn\u011b s BPC-157<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Pro \u00fapln\u00e9 metodologick\u00e9 srovn\u00e1n\u00ed v\u010detn\u011b d\u00e1vkovac\u00edch protokol\u016f a kdy v\u00fdzkumn\u00edci vol\u00ed jeden nad druh\u00fdm, p\u0159e\u010dt\u011bte si <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: kter\u00fd hojiv\u00fd peptid pro v\u00e1\u0161 rekonvalen\u010dn\u00ed c\u00edl<\/a>.<\/p>\n<h2>Skladov\u00e1n\u00ed a rekonstituce<\/h2>\n<p><strong>P\u0159ed rekonstituci:<\/strong> Skladujte lyofilizovan\u00e9 lahvi\u010dky v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu. Lyofilizovan\u00fd BPC-157 je za t\u011bchto podm\u00ednek stabiln\u00ed a\u017e 36 m\u011bs\u00edc\u016f. Vyvarujte se cykl\u016fm zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed pr\u00e1\u0161ku.<\/p>\n<p><strong>Postup rekonstituce:<\/strong> Injektujte bakteriostatickou vodu po bo\u010dn\u00ed st\u011bn\u011b lahvi\u010dky s peptidem (ne p\u0159\u00edmo na lyofilizovan\u00fd kol\u00e1\u010d) podle v\u00fd\u0161e uveden\u00e9 tabulky \u0159ed\u011bn\u00ed. Jemn\u011b zakru\u017ete \u2013 <strong>ne<\/strong> net\u0159epejte \u2013 a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok by m\u011bl b\u00fdt \u010dir\u00fd a bezbarv\u00fd.<\/p>\n<p><strong>Po rekonstituci:<\/strong> Skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C a pou\u017eijte do 30 dn\u016f pro optim\u00e1ln\u00ed stabilitu. Nepou\u017e\u00edvejte zmra\u017een\u00fd rekonstituovan\u00fd roztok \u2013 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed degraduj\u00ed integritu peptidu. Zlikvidujte jakoukoli lahvi\u010dku projevuj\u00edc\u00ed z\u00e1kal, sra\u017eeniny nebo zm\u011bnu barvy.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>K \u010demu se pou\u017e\u00edv\u00e1 BPC-157 ve v\u00fdzkumu?<\/h3>\n<p>BPC-157 se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu k vy\u0161et\u0159ov\u00e1n\u00ed hojen\u00ed \u0161lach a vaz\u016f, integrity st\u0159evn\u00ed bari\u00e9ry, regenerace kostern\u00edho svalstva, vaskul\u00e1rn\u00ed angiogeneze, protiz\u00e1n\u011btliv\u00e9 signalizace a hojen\u00ed kost\u00ed. Je <strong>ne<\/strong> schv\u00e1leno FDA a je zde prod\u00e1v\u00e1no v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<h3>Jak\u00fd je rozd\u00edl mezi BPC-157 a TB-500?<\/h3>\n<p>BPC-157 je 15-aminokyselinov\u00fd pentadekapeptid odvozen\u00fd ze \u017ealude\u010dn\u00ed \u0161\u0165\u00e1vy, p\u016fsob\u00edc\u00ed p\u0159ev\u00e1\u017en\u011b lok\u00e1ln\u011b prost\u0159ednictv\u00edm VEGF, oxidu dusnat\u00e9ho a r\u016fstov\u011b-hormon\u00e1ln\u00edch receptorov\u00fdch drah. TB-500 je 43-aminokyselinov\u00fd thymick\u00fd peptid, kter\u00fd p\u016fsob\u00ed syst\u00e9mov\u011b vazbou na G-aktin a migrac\u00ed bun\u011bk. Tyto dva peptidy jsou \u010dasto ve v\u00fdzkumu pod\u00e1v\u00e1ny spole\u010dn\u011b, proto\u017ee jejich mechanismy jsou sp\u00ed\u0161e komplement\u00e1rn\u00ed ne\u017e p\u0159ekr\u00fdvaj\u00edc\u00ed se.<\/p>\n<h3>Jak\u00e1 je typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka BPC-157?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 protokoly obvykle pou\u017e\u00edvaj\u00ed 250\u2013500 mcg na d\u00e1vku, pod\u00e1vanou jednou nebo dvakr\u00e1t denn\u011b v cyklech trvaj\u00edc\u00edch 4\u20138 t\u00fddn\u016f. 5 mg lahvi\u010dka rekonstituovan\u00e1 s 2,0 mL bakteriostatick\u00e9 vody poskytne koncentraci 2,5 mg\/mL \u2014 10 d\u00edlek na U-100 st\u0159\u00edka\u010dce odpov\u00edd\u00e1 250 mcg.<\/p>\n<h3>Je BPC-157 schv\u00e1leno FDA?<\/h3>\n<p>Ne. BPC-157 nen\u00ed schv\u00e1leno FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. Ve\u0161ker\u00e9 BPC-157 prod\u00e1van\u00e9 dodavateli pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je ur\u010deno pro laboratorn\u00ed v\u00fdzkum a nem\u011blo by b\u00fdt pod\u00e1v\u00e1no lidem.<\/p>\n<h3>Jak by m\u011blo b\u00fdt BPC-157 skladov\u00e1no?<\/h3>\n<p>Lyofilizovan\u00e9 vialky: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu, stabilita a\u017e 36 m\u011bs\u00edc\u016f. P\u0159ipraven\u00fd roztok: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, pou\u017eijte do 30 dn\u016f. P\u0159ipraven\u00fd roztok nezmrazujte \u2014 mrazic\u00ed cykly peptid degraduj\u00ed.<\/p>\n<h3>Jak m\u00e1m rekonstituovat BPC-157?<\/h3>\n<p>Postupujte podle v\u00fd\u0161e uveden\u00e9ho referen\u010dn\u00edho sch\u00e9matu pro rekonstituci. P\u0159idejte bakteriostatickou vodu po stran\u011b lahvi\u010dky (ne p\u0159\u00edmo na lyofilizovanou hmotu), jemn\u011b zakru\u017ete a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Ne <strong>ne<\/strong> prot\u0159ep\u00e1vejte lahvi\u010dku.<\/p>\n<h3>Jak\u00e9 s\u00edly nab\u00edz\u00ed MedsBase?<\/h3>\n<p>MedsBase nab\u00edz\u00ed BPC-157 v lyofilizovan\u00fdch lahvi\u010dk\u00e1ch o obsahu 2 mg, 5 mg a 10 mg. Ka\u017ed\u00e9 mno\u017estv\u00ed je dostupn\u00e9 v balen\u00edch po 10, 20 nebo 30 lahvi\u010dk\u00e1ch. V\u0161echny lahvi\u010dky jsou dod\u00e1v\u00e1ny s \u010distotou 99 %+ HPLC a certifik\u00e1tem anal\u00fdzy na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<h3>Lze BPC-157 a TB-500 ve v\u00fdzkumu kombinovat?<\/h3>\n<p>Ano. BPC-157 a TB-500 jsou \u010dasto pod\u00e1v\u00e1ny spole\u010dn\u011b v preklinick\u00e9m v\u00fdzkumu, proto\u017ee jejich mechanismy p\u016fsoben\u00ed se dopl\u0148uj\u00ed. BPC-157 p\u016fsob\u00ed p\u0159ev\u00e1\u017en\u011b lok\u00e1ln\u011b prost\u0159ednictv\u00edm zv\u00fd\u0161en\u00ed r\u016fstov\u00fdch faktor\u016f; TB-500 p\u016fsob\u00ed syst\u00e9mov\u011b vazbou na G-aktin a migrac\u00ed bun\u011bk. Kombinovan\u00e9 protokoly jsou pops\u00e1ny v na\u0161em <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-vs-tb-500-comparison-guide\/\">srovn\u00e1vac\u00edm pr\u016fvodci<\/a>.<\/p>\n<h3>Zp\u016fsobuje BPC-157 vedlej\u0161\u00ed \u00fa\u010dinky ve v\u00fdzkumu?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 studie na hlodavc\u00edch uv\u00e1d\u011bj\u00ed v\u00fdrazn\u011b \u010dist\u00fd bezpe\u010dnostn\u00ed profil p\u0159i typick\u00fdch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch, bez konzistentn\u00edch ne\u017e\u00e1douc\u00edch sign\u00e1l\u016f a s dobrou toleranc\u00ed. Dlouhodob\u00e9 \u00fadaje o bezpe\u010dnosti u lid\u00ed nejsou k dispozici, proto\u017ee klinick\u00e9 studie nebyly dokon\u010deny.<\/p>\n<h3>Jak\u00fd je rozd\u00edl mezi peror\u00e1ln\u00edm a injek\u010dn\u00edm BPC-157 ve v\u00fdzkumu?<\/h3>\n<p>BPC-157 je neobvykle stabiln\u00ed v \u017ealude\u010dn\u00ed kyselin\u011b d\u00edky sv\u00e9mu p\u016fvodu z \u017ealude\u010dn\u00ed \u0161\u0165\u00e1vy, tak\u017ee peror\u00e1ln\u00ed pod\u00e1n\u00ed je provediteln\u00e9 v protokolech pro hlodavce (na rozd\u00edl od v\u011bt\u0161iny peptid\u016f). Subkut\u00e1nn\u00ed injekce z\u016fst\u00e1v\u00e1 nej\u010dast\u011bj\u0161\u00ed v\u00fdzkumnou cestou v literatu\u0159e, proto\u017ee poskytuje reprodukovateln\u011bj\u0161\u00ed plazmatick\u00e9 koncentrace.<\/p>\n<h3>Jak\u00fd je polo\u010das rozpadu BPC-157?<\/h3>\n<p>V preklinick\u00e9m v\u00fdzkumu m\u00e1 BPC-157 odhadovan\u00fd plazmatick\u00fd polo\u010das rozpadu p\u0159ibli\u017en\u011b 4 hodiny po subkut\u00e1nn\u00edm pod\u00e1n\u00ed. Studie peror\u00e1ln\u00edho pod\u00e1n\u00ed u hlodavc\u016f nazna\u010duj\u00ed krat\u0161\u00ed syst\u00e9movou clearance, ale trval\u00e9 lok\u00e1ln\u00ed \u00fa\u010dinky v gastrointestin\u00e1ln\u00edm traktu, co\u017e je p\u0159i\u010d\u00edt\u00e1no neobvykl\u00e9 odolnosti peptidu v\u016f\u010di kyselin\u00e1m.<\/p>\n<h3>Jak dlouho trv\u00e1, ne\u017e se projev\u00ed \u00fa\u010dinky BPC-157 v preklinick\u00e9m v\u00fdzkumu?<\/h3>\n<p>V\u011bt\u0161ina preklinick\u00fdch studi\u00ed vyu\u017e\u00edvaj\u00edc\u00edch BPC-157 u model\u016f poran\u011bn\u00ed \u0161lach, vaz\u016f a st\u0159ev uv\u00e1d\u00ed m\u011b\u0159iteln\u00e9 zm\u011bny na tk\u00e1\u0148ov\u00e9 \u00farovni do 7\u201314 dn\u016f. \u010casov\u00fd pr\u016fb\u011bh se li\u0161\u00ed v z\u00e1vislosti na v\u00fdzkumn\u00e9m modelu, z\u00e1va\u017enosti poran\u011bn\u00ed, zp\u016fsobu pod\u00e1n\u00ed a d\u00e1vce pou\u017eit\u00e9 v n\u00e1vrhu studie.<\/p>\n<h3>Mohu objednat BPC-157 pro mezin\u00e1rodn\u00ed dopravu?<\/h3>\n<p>Ano. MedsBase expeduje BPC-157 po cel\u00e9m sv\u011bt\u011b prost\u0159ednictv\u00edm na\u0161\u00ed specializovan\u00e9 s\u00edt\u011b pro p\u0159epravu peptid\u016f. Samostatn\u00e9 objedn\u00e1vky peptid\u016f maj\u00ed n\u00e1rok na na\u0161i samostatnou slu\u017ebu p\u0159epravy peptid\u016f. V\u0161echny objedn\u00e1vky jsou odes\u00edl\u00e1ny v termoregulovan\u00e9m balen\u00ed s kompletn\u00edm sledov\u00e1n\u00edm.<\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Protokoly BPC-157 pro regeneraci \u0161lach, vaz\u016f a m\u011bkk\u00fdch tk\u00e1n\u00ed obvykle kombinuj\u00ed tento peptid s TB-500 pro synergick\u00e9 angiogenn\u00ed a cytoskelet\u00e1ln\u00ed \u00fa\u010dinky; pro kombinovan\u00fd re\u017eim viz na\u0161e <a href=\"\/cs\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + bakteriostatick\u00e1 voda)<\/a> s ob\u011bma lyofilizovan\u00fdmi vialami a rekonstitu\u010dn\u00ed vodou v jedn\u00e9 z\u00e1silce za cenu $0 za p\u0159epravu peptid\u016f.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed peptidy pro v\u00fdzkum regenerace a v\u00fdkonnosti<\/h2>\n<ul>\n<li><a href=\"\/cs\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Fragment Thymosin Beta-4 \u2014 v\u00fdzkum regenerace m\u011bkk\u00fdch tk\u00e1n\u00ed a c\u00e9v<\/li>\n<li><a href=\"\/cs\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektivn\u00ed agonista ghrelinu \u2014 \u010dist\u00fd pulz r\u016fstov\u00e9ho hormonu bez kortizolu\/prolaktinu<\/li>\n<li><a href=\"\/cs\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 Analog GHRH s prodlou\u017een\u00fdm polo\u010dasem<\/li>\n<li><a href=\"\/cs\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 M\u011b\u010fn\u00fd peptid \u2014 v\u00fdzkum regenerace k\u016f\u017ee a pojivov\u00e9 tk\u00e1n\u011b<\/li>\n<li><a href=\"\/cs\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolick\u00fd \/ regenera\u010dn\u00ed v\u00fdzkum<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Seznamte se s v\u00fdzkumem tohoto peptidu<\/strong><\/p>\n<p style=\"margin: 0;\">P\u0159e\u010dt\u011bte si n\u00e1\u0161 kompletn\u00ed pr\u016fvodce zalo\u017een\u00fd na d\u016fkazech: <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-peptide-healing-recovery-guide\/\"><strong>BPC-157 \u2014 mechanismus, klinick\u00e1 data a perspektivy<\/strong><\/a>. Pokr\u00fdv\u00e1 mechanismus \u00fa\u010dinku, publikovan\u00e1 v\u00fdzkumn\u00e1 data, obvykl\u00e9 rozsahy v\u00fdzkumn\u00e9ho d\u00e1vkov\u00e1n\u00ed, protokoly pro rekonstituci, mo\u017enosti kombinace a pozn\u00e1mky k bezpe\u010dnosti\/kontraindikac\u00edm.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Podporuje bun\u011b\u010dnou regeneraci<br \/>\n\u2705 Zlep\u0161uje modelov\u00e1n\u00ed tk\u00e1n\u00ed<br \/>\n\u2705 Podporuje aktivitu fibroblast\u016f<br \/>\n\u2705 Stimuluje angiogenn\u00ed signalizaci<br \/>\n\u2705 Zlep\u0161uje stabilitu extracelul\u00e1rn\u00ed matrix<\/p>\n<p><strong>BPC-157<\/strong> obsahuje syntetickou peptidovou slou\u010deninu.<\/p>","protected":false},"featured_media":70942,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5430,5441],"class_list":{"0":"post-68745","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-bpc-157","8":"product_tag-bpc-157-peptide","9":"product_tag-peptide","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/68745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=68745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70942"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=68745"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=68745"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=68745"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=68745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}